Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Involvement of MicroRNA in Microglia-Mediated Immune Response.
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.
The major myelin-resident protein PLP is transported to myelin membranes via a transcytotic mechanism: involvement of sulfatide.
Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders.
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.
Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.
Deficiency of IκB Kinase β in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis.
Integrity of the anterior visual pathway and its association with ambulatory performance in multiple sclerosis.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden.
Cytokine control of inflammation and repair in the pathology of multiple sclerosis.
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI.
Use of botulinum toxin for genitourinary conditions: What is the evidence?
Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Muscle Expression of SOD1(G93A) Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Inflammatory bowel disease: An increased risk factor for neurologic complications.
Pages
« first
‹ previous
…
427
428
429
430
431
432
433
434
435
…
next ›
last »